Oculis Holding AG (OCS) Beginning Cash Balance (2020 - 2026)
Oculis Holding AG (OCS) posted quarterly Beginning Cash Balance of $103.9 million for Q1 2026, up 237.0% year-over-year from $30.8 million in Q1 2025, and up 237.0% quarter-over-quarter from $30.8 million in Q1 2025.
Analysis
Oculis Holding AG (OCS) Beginning Cash Balance (2020 - 2026) Analysis & Trends
Oculis Holding AG's Beginning Cash Balance history runs 4 years deep, the most recent figure standing at $103.9 million for Q1 2026.
- In Q1 2026, Beginning Cash Balance rose 237.0% year-over-year to $103.9 million; the TTM figure through Mar 2026 stood at $103.9 million (up 237.0% YoY), while the FY2025 annual figure was $33.4 million, down 23.29% from the prior year.
- Beginning Cash Balance for Q1 2026 stood at $103.9 million, up from $30.8 million in the prior quarter.
- The five-year high for Beginning Cash Balance was $103.9 million in Q1 2026, with the low at $21.4 million in Q1 2023.
- The 4-year median for Beginning Cash Balance is $37.4 million (2024), against an average of $50.0 million.
- The sharpest annual moves came in 2025 and 2026: Beginning Cash Balance decreased 29.82% in 2025, then jumped 237.0% in 2026.
- Oculis Holding AG's Beginning Cash Balance stood at $21.4 million in 2023, then surged by 105.27% to $43.9 million in 2024, then dropped by 29.82% to $30.8 million in 2025, then soared by 237.0% to $103.9 million in 2026.
- Business Quant data shows OCS's Beginning Cash Balance at $103.9 million in Q1 2026, $30.8 million in Q1 2025, and $43.9 million in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Oculis Holding AG | 634.75 Mn | 345.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 102.90 Mn |
| Mar 31, 2026 | 103.86 Mn |
| Dec 31, 2025 | 34.67 Mn |
| Sep 30, 2025 | 34.64 Mn |
| Jun 30, 2025 | 33.47 Mn |
| Mar 31, 2025 | 30.82 Mn |
| Dec 31, 2024 | 43.75 Mn |
| Sep 30, 2024 | 44.24 Mn |
| Jun 30, 2024 | 42.38 Mn |
| Mar 31, 2024 | 43.91 Mn |
| Dec 31, 2023 | 22.31 Mn |
| Sep 30, 2023 | 22.40 Mn |
| Jun 30, 2023 | 22.01 Mn |
| Mar 31, 2023 | 21.39 Mn |
| Dec 31, 2022 | 48.04 Mn |
| Sep 30, 2022 | 47.92 Mn |
| Jun 30, 2022 | 48.05 Mn |
| Dec 31, 2021 | 5.37 Mn |
| Dec 31, 2020 | 13.44 Mn |